510(k) Report

PMA · Approved

Approved

Collagraft (TM) Bone Graft Substitute

P900039PMAApproved May 28, 19931,099-day reviewClass III

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Neucoll, Inc. · MBS Filler, Bone Void, Non-Osteoinduction

Approved on May 28, 1993 through premarket approval, which rests on the device’s own clinical evidence after a 1,099-day review.

Decided
May 28, 1993
Review
1,099 days
Class
Class III
Product code
MBS
Recalls
None

PMA approvals rest on their own clinical evidence and do not claim a predicate, so this family tree starts here.

P900039 has 13 supplements since 1993: changes to the approved device, its labelling or its manufacturing, each approved separately.

PMA supplements approved per year

1993: 21994: 21995: 31996: 11998: 12002: 22004: 12005: 1
1993high 3 (1995) · low 0 (1997)2005
View FIG. 1 as a table
YearSupplements approved
19932
19942
19953
19961
19981
20022
20041
20051
FIG. 1 — Supplements to P900039, 1993–2005Source: FDA PMA database

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA PMA database (decision fields and supplements), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MBS? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

Does it have a predicate?

PMA decisions do not claim a predicate device.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All MBS devices

MBS Filler, Bone Void, Non-Osteoinduction: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · MBS

FDA has decided no MBS device since 2007.

Median 510(k) review, days · MBS

Too few MBS 510(k)s in any year since 2007 to give a median.

Recalls per year · MBS

No recall names MBS since 2007.

Adverse event reports per year · MBS

6in 2025

2008: 12011: 12018: 12023: 42024: 252025: 6
2007high 25 (2024) · low 0 (2007)2025

MAUDE reports naming product code MBS, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—01
20090—00
20100—00
20110—01
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—01
20190—00
20200—00
20210—00
20220—00
20230—04
20240—025
20250—06
20260—0—
Cite this page

510(k) Report. “P900039: Collagraft (TM) Bone Graft Substitute.” Lineage record from FDA PMA data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/P900039

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026